John A Orwin Insider Trading $ARRY ARRAY BIOPHARMA INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for John A Orwin.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of John A Orwin. John A Orwin is in ARRAY BIOPHARMA INC ($ARRY) and Director in ARRAY BIOPHARMA INC ($ARRY) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in NeurogesX Inc ($NGSX) and President & CEO in Relypsa Inc ($RLYP) and Director in Retrophin, Inc. ($RTRX) and President & CEO in Atreca, Inc. ($BCEL).

John A Orwin in ARRAY BIOPHARMA INC

Trading Symbol: ARRY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John A Orwin: Director
Holdings: 5,000 shares
Current Value: $52,650
Latest Transaction: Jul 30 2019
$ARRY Market Capitalization: $1.80B
$ARRY Previous Close: $10.53

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of John A Orwin in ARRAY BIOPHARMA INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARRY, BCEL, NGSX, RLYP, SGEN, RTRX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 30 2019ARRYARRAY BIOPHARMA IN ...Orwin John ADirectorOption ExerciseD14.5525,000363,7500
Jul 30 2019ARRYARRAY BIOPHARMA IN ...Orwin John ADirectorOption ExerciseD10.4725,000261,7500
Jul 30 2019ARRYARRAY BIOPHARMA IN ...Orwin John ADirectorOption ExerciseD5.9525,000148,7500
Jul 30 2019ARRYARRAY BIOPHARMA IN ...Orwin John ADirectorOption ExerciseD5.1325,000128,2500
Jul 30 2019ARRYARRAY BIOPHARMA IN ...Orwin John ADirectorOption ExerciseD3.8725,00096,7500
Jul 30 2019ARRYARRAY BIOPHARMA IN ...Orwin John ADirectorOption ExerciseD5.6025,000140,0000
Jul 30 2019ARRYARRAY BIOPHARMA IN ...Orwin John ADirectorOption ExerciseD4.5120,00090,2000
Jul 30 2019ARRYARRAY BIOPHARMA IN ...Orwin John ADirectorSellD0.005,000005 K to 0 (-100.00 %)
Jul 30 2019ARRYARRAY BIOPHARMA IN ...Orwin John ADirectorSellD48.0015,000720,0005,00020 K to 5 K (-75.00 %)
Oct 29 2018ARRYARRAY BIOPHARMA IN ...Orwin John AOption ExerciseM0.005,00000
Oct 29 2018ARRYARRAY BIOPHARMA IN ...Orwin John AOption ExerciseA0.005,00005,000
Oct 29 2018ARRYARRAY BIOPHARMA IN ...Orwin John AOption ExerciseA0.0025,000025,000
Oct 29 2018ARRYARRAY BIOPHARMA IN ...Orwin John ABuyM0.005,000015,00010 K to 15 K (+50.00 %)
Oct 27 2017ARRYARRAY BIOPHARMA IN ...Orwin John AOption ExerciseM0.005,00000
Oct 27 2017ARRYARRAY BIOPHARMA IN ...Orwin John AOption ExerciseA0.005,00005,000
Oct 27 2017ARRYARRAY BIOPHARMA IN ...Orwin John AOption ExerciseA10.4725,000261,75025,000
Oct 27 2017ARRYARRAY BIOPHARMA IN ...Orwin John ABuyM10.475,00052,35010,0005 K to 10 K (+100.00 %)
Oct 31 2016ARRYARRAY BIOPHARMA IN ...Orwin John AOption ExerciseM0.005,00000
Oct 31 2016ARRYARRAY BIOPHARMA IN ...Orwin John AOption ExerciseA5.9525,000148,75025,000
Oct 31 2016ARRYARRAY BIOPHARMA IN ...Orwin John AOption ExerciseA0.005,00005,000
Oct 31 2016ARRYARRAY BIOPHARMA IN ...Orwin John ABuyM5.835,00029,1505,0000 to 5 K
Nov 02 2015ARRYARRAY BIOPHARMA IN ...Orwin John AOption ExerciseA5.1325,000128,25025,000
Nov 02 2015ARRYARRAY BIOPHARMA IN ...Orwin John AOption ExerciseA0.005,00005,000

Page:   1